EXTRACORPOREAL HEART AND LUNG TREATMENTS
We offer extracorporeal membrane oxygenation (ECMO) treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop extracorporeal life support (ECLS) technologies that can be vital for the survival of critically ill patients.[1-3]
We provide solutions that combine both cardiac and pulmonary support on one single technological platform, the Xenios console. It supports gas exchange in the lungs and the cardiovascular system. ECMO thus provides physicians with crucial time for diagnosis and therapy.
Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. As human organs are a mutually linked system, Fresenius Medical Care pursues a multi-organ support approach in Critical Care, drawing on its extensive expertise in extracorporeal blood treatment for acute kidney injury.
We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.
In our daily work, we share a passion for helping people.
For patients. Worldwide. Every day.
Heart & Lung Campus
Join, Learn, Care
Looking for further treatment and product information?
Join our Heart & Lung Campus to explore various e-learning modules, for example expert interviews, best-practice-cases, medical information, hands-on-tutorials and priming instructions.
On demand, 24 hours a day, 7 days a week – whenever you need it.
Thanks a lot for visiting our booth and symposium at EPNV 2023! It was great to see and talk to you!
Thanks a lot for a great EuroELSO in Lisbon! We had a great time talking to you. See you next year!
ISICEM congress 2023
Thanks for a fantastic ISICEM congress 2023! We had a great time talking to you. See you next year!
01. January – 31. December
Germany-wide Fresenius Medical Care congresses
Fresenius Medical Care is represented at numerous trade fairs and congresses throughout Germany. Find out more!
21. – 25. October
ESICM LIVES 2023
36th ESICM's (European Society Of Intensive Care Medicine) annual congress - LIVES
Visit our booth!
Milano Convention Center
 ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Extracorporeal Life Support Organization, Version 1.4 August 2017, Ann Arbor, MI, USA
 Peek, G. et al. (2009). Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 374(9698), 1351–1363
 Combes, A. et al. (2018). Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med, 378(21), 1965–1975